Search research articles
Contact Us
Filters
Showing results (101-110 of 141) with videos related to
Page
of 15
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
September 13, 2003
Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia
Anne E Nelson, Roderick Clifton Bligh, Michiko Mirams, et al.
American Journal of Surgery
|
September 4, 2020
Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer
Carolina Nylén, Frida Bragvad Eriksson, Anna Yang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 11, 2002
Comparative genomic hybridization analysis of adrenocortical tumors
Stan Sidhu, Deborah J Marsh, George Theodosopoulos, et al.
Cancer
|
December 5, 2013
MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer
James C Lee, Jing Ting Zhao, Roderick J Clifton-Bligh, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 22, 2017
Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study
Jes Sloth Mathiesen, Mouhammed Amir Habra, John Howard Duncan Bassett, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 13, 2009
The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors
Lyndal J Tacon, Patsy S Soon, Anthony J Gill, et al.
Annals of Surgery
|
December 25, 2007
Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors
Patsy S H Soon, Rossella Libe, Diana E Benn, et al.
Endocrinology
|
December 15, 2007
Wnt pathway inhibitors are strongly down-regulated in pituitary tumors
Marianne S Elston, Anthony J Gill, John V Conaglen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial
Samuel A Wells, Bruce G Robinson, Robert F Gagel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2009
miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
Patsy Siok Hwa Soon, Lyndal J Tacon, Anthony J Gill, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 141) with videos related to
Sort By:
Page
of 15
The Journal of Clinical Endocrinology and Metabolism
|
September 13, 2003
Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia
Anne E Nelson, Roderick Clifton Bligh, Michiko Mirams, et al.
American Journal of Surgery
|
September 4, 2020
Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer
Carolina Nylén, Frida Bragvad Eriksson, Anna Yang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 11, 2002
Comparative genomic hybridization analysis of adrenocortical tumors
Stan Sidhu, Deborah J Marsh, George Theodosopoulos, et al.
Cancer
|
December 5, 2013
MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer
James C Lee, Jing Ting Zhao, Roderick J Clifton-Bligh, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 22, 2017
Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study
Jes Sloth Mathiesen, Mouhammed Amir Habra, John Howard Duncan Bassett, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 13, 2009
The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors
Lyndal J Tacon, Patsy S Soon, Anthony J Gill, et al.
Annals of Surgery
|
December 25, 2007
Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors
Patsy S H Soon, Rossella Libe, Diana E Benn, et al.
Endocrinology
|
December 15, 2007
Wnt pathway inhibitors are strongly down-regulated in pituitary tumors
Marianne S Elston, Anthony J Gill, John V Conaglen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial
Samuel A Wells, Bruce G Robinson, Robert F Gagel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2009
miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
Patsy Siok Hwa Soon, Lyndal J Tacon, Anthony J Gill, et al.
Page
of 15